Effects of Toxic Metals on Learning Ability and Behavior

0 Flares Twitter 0 Facebook 0 Google+ 0 LinkedIn 0 0 Flares ×

Mechanisms of Developmental Damage by Toxic Metals

The human brain forms and develops over a longer period of time compared to other organs, with neuron proliferation and migration continuing in the postnatal period. The blood-brain barrier is not fully developed until the middle of the first year of life. Similarly, there is postnatal activity in the development of neuronal receptors and transmitter systems, as well as in the production of myelin. The fetus has been found to get significant exposure to toxic substances through maternal blood and across the placenta, with fetal levels of toxic metals often being higher than that of maternal blood. Likewise, infants have been found to get significant exposure to toxics through breastfeeding, such as mercury and organochlorine compounds that their mother is exposed to.

The incidence of neurotoxic or immune reactive conditions such as autism, schizophrenia, ADD, dyslexia, learning disabilities, etc. have been increasing rapidly in recent years. A recent report by the National Research Council found that 50% of all pregnancies in the U.S. now result in prenatal or postnatal mortality, significant birth defects, developmental neurological problems, or otherwise chronically unhealthy babies. There has been a similar sharp increase in developmental conditions in Canadian children, including increases in learning disabilities and behavioral problems, asthma and allergies, and childhood cancer. Not all children are equally affected by a given level of toxic exposures, and susceptibility factors such as immune reactivity, genetic factors affecting ability to excrete toxic metals, and other toxic exposures have major influences on toxicity effects.

A 2009 study found that inorganic mercury levels in people have been increasing rapidly in recent years. It used data from the U.S. Centers for Disease Control and Prevention’s National Health Nutrition Examination Survey (NHANES), finding that, while inorganic mercury was detected in the blood of 2% of women age 18 to 49 in the 1999-2000 NHANES survey, that level rose to 30% of women by 2005-2006. Surveys in all states using hair tests have found dangerous levels of mercury in an average of 22% of the population, with over 30% in some states like Florida and New York.

Studies and clinical experience at treatment clinics have found consistently that gastrointestinal, immunologic and metabolic problems— related to prenatal and neonatal exposure to toxic substances with much of these being related to vaccinations—are found in children with ADHD. Lower GI dysfunction, enzyme deficiencies, and impairment of hepatic detoxification pathways are very common. Many ADHD/autism patients have “leaky gut” syndrome and inability to digest wheat gluten and milk casein, resulting in neurotoxic substances being dumped in the blood with significant adverse behavioral impacts.

Exposure to toxic chemicals or environmental factors appear to be a factor in at least 28% of the four million U.S. children born each year, with at least one in six having one of the neurological conditions previously listed according to the U.S. Census Bureau. U.S. EPA estimates that over three million of these are related to lead or mercury toxicity, with approximately 25% of U.S. children receiving mercury exposure at dangerous levels. Evidence indicates that over 60,000 children are born each year with neurodevelopmental impairment due to methylmercury, with even higher levels of exposure and impairment from two other sources, vaccines, and mother’s amalgam dental fillings.

Extent of Exposure of Children to Toxic Metals

The U.S. Center for Disease Control ranks toxic metals as the number one environmental health threat to children, adversely affecting large numbers of children in the U.S. each year and thousands in Florida. According to an EPA/ATSDR assessment, the toxic metals lead, mercury, and arsenic are the top three toxics having the most adverse health effects on the public based on toxicity and current exposure levels in the U.S. Cadmium, chromium and nickel are also highly listed. According to the American Academy of Child and Adolescent Psychiatry, an estimated one out of every six children in the U.S. have blood levels of lead in the toxic range, and studies estimate that over twelve million children suffer from learning, developmental, and behavioral disabilities including ADD, autism, schizophrenia, and mental retardation. Large numbers of people have been found to have allergic conditions and immune reactive autoimmune conditions due to the toxic metals, especially inorganic mercury and nickel. These metals have also been found to diminish the cellular ATP energy function and be related to chronic fatigue. One of the mechanisms documented is causing intestinal dysbiosis, resulting in poor vitamin and mineral absorption and “leaky gut.”

The level of exposure in most infants to mercury thimerosal has been found to be many times higher than the federal limits for mercury exposure. The largest increase in neurological problems has been in infants, with an increase in autism cases to over 500,000, an over 500% increase to a level of almost one per 300 infants in the last decade, making it the 3rd most common chronic childhood condition, along with similar increases in ADD. According to the American Academy of Pediatrics between 4 to 12% of all school age children are affected by ADHD, and a similar number have some degree of dyslexia. However, large surveys of elementary level student records fond much higher levels, with over 20% of elementary school boys in some areas being treated for ADD. Similar levels of children have been found to have mood or anxiety disorders. At least 4% of adults have also been found to have ADHD symptoms. Studies have found that long-term use of stimulant drugs commonly is not effective in the long run and causes significant adverse neurological and health effects. There are more effective options available to deal with such conditions without such adverse effects, including dealing with the underlying causes as well as diet, exercise, and supplement options that deal with underlying deficiencies.

The heavy metals (lead, mercury, cadmium, nickel) tend to concentrate in the air and in the food chain along with other toxic metals, facilitating metal poisoning which is the most widespread environmental disorder in the U.S. Mercury and cadmium from combustion emissions are also accumulating in coastal estuaries and inland water body sediments and are widespread in shellfish and other organisms. Mercury and cadmium are extremely toxic at very low levels and have serious impacts on the organisms in water bodies that accumulate them. These heavy metals have also been found to be endocrine system disrupting chemicals and have been found to be having effects on the endocrine and reproductive systems of fish, animals, and people, similar to the reproductive and developmental effects of organochlorine chemicals. Estrogenic chemicals, like mercury, have been found in Florida wildlife at levels that feminized males to the extent of not being able to reproduce and also had adverse effects on the female reproductive systems. Similar effects have also been documented in humans.

Developmental Effects of Toxic Metals on Cognitive Ability and Behavior

Studies have found that heavy metals, such as mercury, cadmium, lead, aluminum, and tin, affect chemical synaptic transmission in the brain and the peripheral and central nervous system. They also have been found to disrupt brain and cellular calcium levels that significantly affect many body functions, such as:

  • calcium levels in the brain affecting cognitive development and degenerative CNS diseases;
  • calcium-dependent neurotransmitter release which results in depressed levels of serotonin, norepinephrine, and acetylcholine—related to mood and motivation;
  • cellular calcium-sodium ATP pump processes affecting cellular nutrition and energy production processes; and
  • calcium levels in bones causing skeletal osteodystery.

Toxic metals have also been found to affect cellular transfer and levels of other important minerals and nutrients that have significant neurological and health effects such as magnesium, lithium, zinc, iron, vitamins B-6 and B1-12. Based on thousands of hair tests, at least 20% of Americans are deficient in magnesium and lithium, with zinc deficiencies also common and iron deficiencies. The resulting deficiency of such essential nutrients has been shown to increase toxic metal neurological damage. Cerebrospinal magnesium was found to be significantly lower in both depression and adjustment disorder and in those who have attempted suicide.

Much of the developmental effects of mercury (and other toxic metals) are due to prenatal and neonatal exposures damage to the developing endocrine (hormonal) system. A recent study found that prenatal Hg exposure is correlated with lower scores in neurodevelopmental screening but more so in the linguistic pathway. Prenatal and neonatal toxic metal exposure to mercury, lead, arsenic, cadmium, nickel, and aluminum have been documented in medical publications to cause common and widespread neurological and psychological effects, including depression, anxiety, obsessive compulsive disorders, social deficits, other mood disorders, schizophrenia, anorexia, cognitive impairments, ADHD, autism, seizures, etc.

Children with autism had significantly higher levels of mercury in baby teeth but similar levels of lead and similar levels of zinc. Children with autism also had significantly higher usage of oral antibiotics during their first twelve months of life. Baby teeth are a good measure of cumulative exposure to toxic metals during fetal development and early infancy.

Studies have also found heavy metals to deplete glutathione and bind to protein-bound sulfhydryl SH groups, resulting in inhibiting SH-containing enzymes and production of reactive oxygen species, such as superoxide ion, hydrogen peroxide, and hydroxyl radical. In addition to forming strong bonds with SH and other groups like OH, NH2, and Cl in amino acids which interfere with basic enzymatic processes, toxic metals exert part of their toxic effects by replacing essential metals such as zinc at their sites in enzymes. An example of this is mercury’s disabling of the metallothionein protein, which is necessary for the transport and detoxification of metals. Mercury inhibits sulfur ligands in MT and in the case of intestinal cell membranes inactivates MT that normally binds cuprous ions, thus allowing buildup of copper to toxic levels in many and malfunction of the Zn/Cu SOD function. Another large study found a high percentage of autistic and PDD children are especially susceptible to metals due to the improper functioning of their metallothionein detoxification process, and most recover with proper treatment. Mercury has also been found to play a part in neuronal problems through blockage of the P-450 enzymatic process.

Mercury-induced reactive oxygen species and lipid peroxidation has been found to be a major factor in mercury’s neurotoxicity, along with leading to decreased levels of glutathione peroxidation and superoxide dismutase (SOD). This has been found to be a major factor in neurological and immune damage caused by the heavy metals, including damage to mitochondria and DNA, as well as chronic autoimmune conditions and diseases. Turmeric (curcumin) has strong antioxidant effects and has been shown to counteract lipid peroxidation and toxicity effects of metals and to reduce the toxic effects of metals such as copper, lead, cadmium, etc.

The effects on DNA are a factor in several of the toxic metals such as arsenic, beryllium, cadmium, chromium, and nickel, all of which are known carcinogens, but chronic exposure to other toxic metals, such as mercury, is also known to promote cancer through DNA effects and suppression of the immune system. Metals by binding to SH radicals in proteins and other such groups can cause autoimmunity by modifying proteins which via T-cells activate B-cells that target the altered proteins inducing autoimmunity as well as cause aberrant MHC II expression on altered target cells. Studies have also found mercury and lead cause autoantibodies to neuronal proteins, neurofilaments, and myelin basic protein. Immune mechanisms are a major factor in neurotoxicity of metals seen in conditions, such as autism and ADD.

Although vaccinations appear to be the largest source of mercury in infants, mercury has been found to be transmitted from the mother to the fetus through the placenta and accumulate in the fetus to higher levels than in the mother’s blood. Breast milk of women who have amalgam fillings is the second largest source of mercury in infants and young children, but eating a lot of fish has also been found to be a significant source of methylmercury. Milk increases the bioavailability and retention of mercury by as much as double, and mercury is often stored in breast milk and the fetus at much higher levels than that in the mother’s tissues. Mercury is transferred mainly by binding to casein. The level of mercury in breast milk was found to be significantly correlated with the number of amalgam fillings, with milk from mothers with seven or more fillings having levels in milk approximately ten times that of amalgam-free mothers. The mercury in milk sampled ranged from 0.2 to 6.9 ug/L. Prenatal mercury exposure can also developmentally damage the metals detox system of the liver, which can lead to accumulation and toxicity of later metals exposure.

High lead, copper, manganese, or mercury levels have been found to be associated with attention deficit hyperactivity disorder (ADHD), memory deficits, impulsivity, anger, aggression, inability to inhibit inappropriate responding, juvenile delinquency, and criminality. Mercury has been found to be a factor in anger, aggressive behavior, depression, obsessive compulsive behavior (OCD), ADD, autism, schizophrenia, suicidal behaviors, learning disabilities, anxiety, mood disorders, and memory problems. It has been found that excess levels of copper can cause violent behavior in children. A study that investigated the effects of zinc and copper on the behavior of schizophrenic patients by comparing blood zinc and copper levels in criminal and noncriminal schizophrenic patients found criminal subjects have significantly lower zinc levels and significantly higher copper levels than non-criminal subjects.

Manganese toxicity has long been known to be associated with impulsive and violent behavior. Lead also has been the subject of extensive research documenting its relation to all of these conditions. Based on a national sample of children, there is a significant association of lead/body burden with aggressive behavior, crime, juvenile delinquency, and behavioral problems. By the government’s latest count, 2.2% of children ages one to five in the United States have a blood/lead level that is greater than or equal to 10 micrograms per deciliter of blood, a level that studies have shown to be associated with adverse effects. In a recent study after adjustment for covariates and interactions and removal of non-influential covariates, adjudicated delinquents were four times more likely to have bone/lead concentrations 25 ppm more than controls.

High aluminum levels have been found to be related to encephalopathies and dementia. Scores for tension, depression, anger, fatigue, and confusion in workers exposed to aluminum for more than ten years were significantly more than those in non-exposed controls. Recent studies suggest that aluminum contributes to neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, senile and pre-senile dementia, clumsiness of movements, staggering when walking, and inability to pronounce words properly. Arsenic, like most of the other metals, has been found in studies to be associated with neurologic, vascular, dermatologic, and carcinogenic effects, along with reproductive effects. Long-term exposure to ingested arsenic has been documented to induce peripheral vascular disease, carotid arteriosclerosis, ischemic heart disease, and cerebral infarction in a dose-response relationship. A comparison of areas with higher levels of arsenic in the water supply found higher fetal and infant mortality in areas with higher arsenic levels and higher cancer rates. Cadmium is also a known carcinogen. Some of the developmental effects documented to be caused by low level toxic metal exposure include developmental delays, growth problems, slower reaction times, diminished intellectual ability, behavior problems, poor balance and motor function, hearing loss, ADD, etc.

Many individuals have been found to be more sensitive to toxic metals, depending on genetic sensitivity and past exposure to toxic substances. Nickel exposure is common, and nickel exposure has been found to be significantly related to perinatal un-thriftiness and mortality in animal studies. Large numbers of people affected by allergic conditions such as eczema and psoriasis vulgaris and serious autoimmune conditions, such as lupus and CFS, have been found to be immune reactive to nickel or mercury.

Other agents, including mercury, are known to accumulate in endocrine system organs, such as the pituitary gland, thyroid, and hypothalamus, and to alter hormone levels and endocrine system development during crucial periods of development. Such effects are usually permanent and affect the individual throughout their life. Pregnant women who suffer from hypothyroidism (underactive thyroid) have a four times greater risk for miscarriage during the second trimester than those who don’t, and women with untreated thyroid deficiency were four times more likely to have a child with developmental disabilities and lower IQ. Some of the documented effects of exposure to toxic metals include significant learning and behavioral disabilities, cognitive delays, autism, etc. Even some of the relatively subtle effects that have been found to occur include small decreases in IQ, attention span, and connections to delinquency and violence.

The incidence of neurological conditions in children, such as autism, has increased over 500% in the last decade, along with similar increases in ADD and other pervasive developmental diseases (PDD). Autism is a condition that was unknown prior to the 1940s but whose incidence has increased so rapidly that it is currently the 3rd leading childhood neurological conditions, and the current incidence in approximately one in 300 and one in 150 in some communities surveyed in Maryland. Millions of kids are currently afflicted with PDD conditions. Mercury and other toxic metals have been found to be a factor in most of those tested. Vaccinations that use mercury thimerosal as a preservative appear to be a common and causative factor in these conditions as well as SIDS. A study at the U.S. CDC and follow-up studies found “statistically significant associations” between certain neurological developmental disorders, such as attention deficit disorder (ADD) and autism with exposure to mercury from thimerosal-containing vaccines before the age of six months.

A direct mechanism involving mercury’s inhibition of cellular enzymatic processes by binding with the hydroxyl radical (SH) in amino acids appears to be a major part of the connection to these allergic/immune reactive conditions. For example, mercury has been found to strongly inhibit the activity of xanthine oxidase and dipeptyl peptidase (DPP IV), which are required in the digestion of the milk protein casein. CD26 or DPPIV is a cell surfact glycoprotein that is very susceptible to inactivation by mercury binding to its cysteinyl domain. Mercury and other toxic metals also inhibit binding of opioid receptor agonists to opioid receptors, while magnesium stimulates binding to opioid receptors. Studies involving a large sample of autistic and schizophrenic patients found that over 90% of those tested had high levels of the milk protein beta-casomorphin-7 in their blood and urine and defective enzymatic processes for digesting milk protein, and similarly for the corresponding enzyme needed to digest wheat gluten. The studies found high levels of Ig A antigen specific antibodies for casein, lactalbumin and beta-lactoglovulin and IgG and IgM for casein. Beta-casomorphine-7 is a morphine-like compound that results in neural dysfunction, as well as being a direct histamine releaser in humans and inducing skin reactions

Similarly many also had a corresponding form of gluten protein. Elimination of milk and wheat products and sulfur foods from the diet has been found to improve the condition. A double blind study, using a potent opiate antagonist, naltrexone (NAL), produced significant reduction in autistic symptomology among the 56% most responsive to opioid effects. The behavioral improvements were accompanied by alterations in the distribution of the major lymphocyte subsets, with a significant increase in the T-helper-inducers and a significant reduction of the T-cytotoxic-suppressors and a normalization of the CD4/CD8 ratio. Studies have found mercury causes increased levels of the CD8 T-cytotoxic-suppressors. As noted previously, such populations of patients have also been found to have high levels of mercury and to recover after mercury detox. As mercury levels are reduced, the protein binding is reduced and improvement in the enzymatic process occurs.

Additional cellular level enzymatic effects of mercury’s binding with proteins include blockage of sulfur oxidation processes and neurotransmitter amino acids which have been found to be significant factors in many autistics, plus enzymatic processes involving vitamins B6 and B12, with effects on the cytochrome-C energy processes as well. The activating enzyme B6-kinase is totally inhibited in the intestine at extremely low levels (nanamolar) of mercury, with similar effects on B12. Epson salts (magnesium sulfate baths), supplementation with the p5p form of vitamin B6, and vitamin B12 shots are methods of dealing with these enzymatic blockages that have been found effective by those treating such conditions. Mercury and toxic metals have also been found to have adverse effects on cellular mineral levels of calcium, magnesium, zinc, and lithium. Supplementing with these minerals has also been found to be effective in the majority of cases. Another of the results of these toxic exposures and enzymatic blockages is the effect on the liver and dysfunction of the liver detoxification processes which autistic children have been found to have. All of the autistic cases tested were found to have high toxic exposures/effects and liver detoxification profiles outside of normal.

According to studies reviewed, over 20% of the children in the U.S. have had their health or learning adversely affected by toxic metals, and over 50% of children in some urban areas have been adversely affected. Significant behavioral effects were also documented. Such effects similarly affect adults. Many epidemiologists believe the evidence demonstrates that over 50% of all U.S. children have had their learning ability or mental state significantly affected by prenatal and/or postnatal exposure to toxic substances. The toxic metals have been documented to be reproductive and developmental toxins, causing birth defects and damaging fetal development, as well as neurological effects, developmental delays, learning disabilities, depression, and behavioral abnormalities in many otherwise normal-appearing children.

Prenatal exposure to seven heavy metals was measured in a population of pregnant women at approximately 17 weeks gestation. Follow-up tests on the infants at three years of age found that the combined prenatal toxic exposure score was negatively related to performance on the McCarthy Scales of Children’s Abilities and positively related to the number of childhood illnesses reported. Many similar studies measuring child hair levels of the toxic metals aluminum, arsenic, cadmium, lead, and mercury have found that these toxic metals have significant effects on learning ability and cognitive performance, explaining as much as 20% of cognitive differences among randomly tested children who have low levels of exposure not exceeding health guidelines for exposure to any of these metals. These toxic metals have been found to have synergistic negative effects on childhood development and cognitive ability.

Among those more significantly affected by neurological deficits or problems, the affects appear even more significant. Comparison of groups of children who are cognitively challenged or significantly learning disabled to normal controls found significantly higher levels of toxic metals in the affected groups. A study of rural children with subtoxic exposure levels found significantly higher levels of lead and cadmium in a group of mildly retarded/borderline intelligence (IQ 55-84) than controls. 76% of the study group had one of five toxic metals exceeding the lab’s upper safety limit.

A large study found that hair cadmium level is highly correlated with and predictive of very significant learning disability. Over 90% of those with hair cadmium levels of 0.4 ppm or more were found to have significant disabilities, and over 95% of those with levels above 0.7 were cognitively challenged. In a group of students with normal range IQs who failed one subject area on a standardized test (paradigmatic LD), the groups’ cadmium and lead hair levels were significantly higher than controls. Average hair cadmium level in the group with learning disabilities was 1.7 ppm. Similar findings regarding toxic metal exposure levels were found for dyslexic children, schizophrenic children, and autistic children. A study of dyslexic children with normal IQs found the dyslexic group had a cadmium hair level average of 2.6 ppm, 25 times that of the control group and exceeding the maximum of the normal acceptable range. The dyslexic group also had somewhat higher aluminum and copper levels. Studies of groups with schizophrenia have found increased levels of copper and mercury and reduced levels of zinc, magnesium, and calcium, which are known to be inhibited by heavy metals and affect neurotransmitter levels. Results of a study at a teaching hospital showed that cadmium was significantly raised in depressives and reduced in mania patients. Lead was increased in depressives and schizophrenics but not in mania patients. Serum zinc was reduced in all mental patients. A group of violent criminals had significantly higher levels of hair lead and cadmium levels than non-violent controls.

These toxic metals have also been found similarly to have significant behavioral and emotional effects on children and adults. One group of students was scored by their classroom teacher on the Walker Problem Behavior Identification Checklist (WPBIC). A combined hair level score for mercury, lead, arsenic, cadmium and aluminum was found to be significantly related to increased scores on the WPBIC subscales measuring acting-out, disturbed peer relations, immaturity, and the total score among a population of students with no known acute exposures. The combined metals score explained 23% of the difference of the total WPBIC score, and 16 to 29% of the differences on the subscales for withdrawal, acting out, disturbed peer relations, distractibility, and immaturity. Similar results were found in the other studies and have been found to have implications not only in the classroom but also on relations at home, on driving habits, and on job performance.

Studies have found evidence that abnormal metal and trace elements affected by metal exposure appear to be a factor associated with aggressive or violent behavior, and hair trace metal analyses may be a useful tool for identifying those prone to such behavior. It has been found that excess levels of copper can cause violent behavior in children. One mechanism found to be associated with toxic metals and pesticides and aggressive and violent behavior is the documented inhibition of cholinesterase activity in the brain. Another series of studies found abnormal trace metal concentrations to be associated with violent-prone individuals including elevated serum copper and depressed plasma zinc. A group with a history of assaultive and violent-prone behavior had significantly higher median Cu/Zn ratio than for controls. Assaultive, violent-prone individuals usually have abnormal trace-metal concentrations, including elevated serum copper and depressed plasma zinc.

A study of teenagers in Pittsburgh found that having elevated lead was associated with a four-fold risk of delinquency. Similar tests in the California juvenile justice system as well as other studies have found significant relations to classroom achievement, juvenile delinquency, and criminality. Three studies in the California prison system found those in prison for violent activity had significantly higher levels of hair manganese than controls, while other studies in the California prison and juvenile justice systems found that those with five or more essential mineral imbalances were 90% more likely to be violent and 50% more likely to be violent for two or more mineral imbalances. In studies at juvenile delinquency centers, nutritional therapy reduced antisocial and violent behavior by over 50%.

A study analyzing hair of 28 mass murderers found that all had high metals and abnormal essential mineral levels. Like several other studies they found higher levels of such toxic metals in blacks than in Caucasian populations. Studies of an area in Australia with much higher levels of violence as well as autopsies of several mass murderers also found high levels of manganese to be a common factor. Such violent behavior has long been known in those with high manganese exposure. Doctors in UK found a woman’s insanity and violent behavior to be related to poisoning from leaking amalgam dental fillings, and other studies and clinical results have confirmed the connection of toxic metals to behavioral problems and violence. Studies at the Argonne National Laboratory found that the majority of delinquents and criminals had high metals levels, such as cadmium and lead, and to fall into two categories: one group with high copper and low zinc, sodium potassium tended to have extreme tempers, and another group with low zinc and copper but high sodium and potassium tended to be sociopathic. It was found that treatment, including nutritional therapy, of delinquent or violent-prone individuals for metals-related problems usually produced significant improvements in mood, violent behavior, and functionality—with complete cure in the majority of cases.

Lithium protects brain cells against excess glutamate and calcium, and low levels cause abnormal brain cell balance and neurological disturbances. Lithium also is important in vitamin B12 transport and distribution, and studies have found low lithium levels common in learning disabled children, incarcerated violent criminals, and people with heart disease. Lithium supplementation has been found to be an effective treatment adjunct in conditions such as bipolar depression, autism, and schizophrenia where mania or extreme hyperactivity is seen. It has been documented that conditions like depression and other chronic neurological conditions often involve damage and nerve cell death in areas of the brain like the hippocampus, and lithium has been found to not only prevent such damage but also to promote cell gray matter cell growth in such areas and to be effective in treating not only depressive conditions but degenerative conditions, like Huntington’s disease.

Lithium had a significant mood-improving and stabilizing effect on former drug users with psychological conditions. In the study, a group including violent offenders and family abusers were divided into two groups. Half received lithium supplements, and the other half received a placebo. The group getting lithium had significantly increased scores for mood, happiness, friendliness, and energy, while the other group did not. Similar results were obtained for a group of violent former drug users. In a large Texas study, incidence of suicide, homicide, rape, robbery, burglary, theft, and drug use were significantly higher in counties with low lithium levels in drinking water. In a placebo-controlled study on prisoners with a history of impulsive/aggressive behavior, the group taking lithium supplements had a significant reduction in aggressive behavior and infractions involving violence. The authors suggest that for those areas with low lithium levels in water, water systems should add lithium, and those with deficiencies in lithium or displaying aggressive or impulsive behavior would likely benefit from lithium supplements.

Toxic metals and the resulting mineral imbalances have also been found to be a major cause of depression and mood disorders, including schizophrenia and mania. Some factors that have been documented in depression, impulsiveness, and violent behavior are low serotonin levels, abnormal glucose tolerance (hypoglycemia), and low chromium and folate levels, which mercury has also been found to be a cause of. One mechanism by which mercury has been found to be a factor in aggressiveness and violence is its documented inhibition of the brain neurotransmitter acetylcholinesterase. Low serotonin levels and/or hypoglycemia have also been found in the majority of those with impulsive and violent behavior. Toxic metals also influence mood and depression by affecting balances of essential minerals and essential fatty acids, along with blocking essential enzymatic processes, resulting in morphine-like substances in the blood and affecting levels of most brain neurotransmitters. Another well documented mechanism of toxic metal depression inducement is through reducing amino acid levels such as tryptophan and tyrosine which is documented to result in inducing depression, while another is mercury’s promotion of candida albicans overgrowth.

Mercury and lead have been documented to be causes of autism, schizophrenia, mania, ADD, and depression, while vanadium has been found to be a cause of depressive psychosis and mania. Mercury accumulates in the pituitary gland and thus has endocrine system/hormonal effects. In addition to mercury having estrogenic effects, mercury and lead have other documented hormonal effects, including lowered levels of neurotransmitters dopamine, serotonin, and noreprenephrine. Some of the effect on depression is also related to mercury’s effect of reducing the level of posterior pituitary hormone (oxytocin). Low levels of pituitary function are associated with depression and suicidal thoughts and appear to be a major factor in suicide of teenagers and other vulnerable groups. Amalgam fillings, nickel, and gold crowns are major factors in reducing pituitary function. Supplementary oxytocin extract has been found to alleviate many of these mood problems, along with replacement of metals in the mouth. A study following infants to age seven in New Zealand found a significant effect on cognitive and psychological function related to mother’s hair mercury level. A study of children in the Faeroe Islands had a similar finding.

Other endocrine effects of mercury and lead include infertility and other reproductive system problems. Studies have previously found that low levels of lead exposure is significantly related to hyperactivity and attention deficit, depression, school cognitive performance, behavioral problems, mental disorders, allergies, growth, gestational age, and spontaneous abortions. In one study, children’s umbilical cord blood at birth was recorded, and a teacher assessment of learning/behavioral characteristics was completed at the end of the school year at age eight. Girls with higher than average (10 ug/dL) cord blood level were found to be more likely to be dependent, un-persistent, and have an inflexible approach to tasks. Boys with higher than average cord blood level were found to be more likely to have problems following simple directions or sequences of directions. A follow up study to the Cincinnati lead study measured blood lead levels and compared to standardized IQ test scores at approximately 6.5 years of age. The study found blood lead levels were significantly inversely related to both full-scale and performance IQ, and that blood lead levels over 20 ug/dL were related to an average deficit in IQ of seven points on performance IQ as compared to those with below 10 ug/dL blood lead levels. Another study in Australia measured IQ at approximately twelve years of age and compared blood lead levels measured from one to seven years of age. Total, verbal, and performance IQ were all inversely related with blood lead levels measured during the first seven years of life. Two studies found average hair lead levels in groups of learning disabled children over 20 ppm as compared to 4 ppm in controls.

Children with a lead concentration of seven to ten micrograms per deciliter of blood scored an average of 11.1 points lower than the mean on the Stanford-Binet IQ test. The study also found an average 5.5 point decline in IQ for every additional ten microgram increase in blood to lead concentration. Another study found significant IQ reductions approx. 0.74 points per ug/dL lead level increase at exposure levels between 1 ug/L and 10 ug/dL.

However, other studies have pointed out that these studies generally did not investigate or consider the effects and synergistic interactions of the other toxic metals, and the fact that lead and cadmium levels tend to have positive correlations with each other. A study of rural school children without acute exposures and with IQs in the normal range found highly significant relations between lead and cadmium with intelligence scores and school achievement tests. Lead and cadmium explained 29% of the variance in IQ. These two metals have been found to have different mechanisms of CNS damage, with cadmium affecting verbal ability more and lead affecting performance measures more. The author of another study of 9 year olds living in an area near an incinerator in Ohio concluded that part of the developmental effects attributed to lead in many past studies was mostly due to cadmium effects, with lead serving as a marker for cadmium effects due to their common origins and cadmium’s effect of increasing lead accumulation.

The findings of this study were generally consistent with a previous study regarding higher levels of cadmium and lower levels of zinc in children with cognitive deficits. However, this study found zinc level, although significantly affected, can be increased in some depending on other factors. Cadmium, as well as mercury, has anti-metabolite effects that significantly affect calcium, zinc, and phosphate levels in the body. The reduction in zinc levels causes increased absorption of lead, and cadmium’s effect on the pyrimidine-5-nucleotidase enzyme inhibits phosphorylation in the energy/respiratory ATP function. This study found the level of hair phosphorous, as affected by cadmium exposure, was the best indicator of cognitive function and dysfunction. Lead was found to have a lesser effect on phosphorous level and ATP function. The entire group of learning disabled boys had low hair phosphorous levels compared to those without learning disabilities. The main factors appearing to affect those with high cadmium levels and low phosphorous hair levels lived within two miles of the incinerator, had exposure to passive cigarette smoke, and lived in a rural area that may have had high cadmium levels in wells. Another study found heavy smokers have cadmium levels in body tissues about two times that of non-smokers, and hair cadmium levels in newborns of smokers were twice as great as in newborns of non-smokers.

Other studies have found that cadmium causes significant decreases in birth weight through its antimetabolite actions and significant increases in blood pressure. Newborn hair cadmium levels have been found to be significantly correlated to maternal hair levels and mothers exposed occupationally to heavy metals to have hair levels twice as high as controls. Likewise adults with higher than average cadmium levels performed less well on measures of attention, psychomotor speed, and memory. These toxic metals have also been found to have significant effects on motor-visual ability and performance, as measured by the Bender Visual-Motor Gestalt Test score. Arsenic, lead, and cadmium levels had the highest correlation with cognitive scores, while aluminum had a significant relation mostly with motor-visual performance and mercury had lesser but highly significant correlations to both.

Studies have also found evidence of a connection between low levels of zinc and four other common childhood diseases, treatment resistant depression, oppositional defiant disorder, childhood-onset diabetes, and epilepsy. Zinc is an antagonist to toxic metals like cadmium and mercury, and adequate levels are required to balance the adverse effects of these toxic metals on cellular calcium and other enzymatic processes. Other connections between mercury and type I diabetes have also been demonstrated. Mercury has been found to cause an increase in inflammatory Th2 cytokines. In the pancreas, the cells responsible for insulin production can be damaged or destroyed by the chronic high levels of cytokines, with the potential of inducing type II diabetes, even in otherwise healthy individuals with no other risk factors for diabetes. Mercury inhibits production of insulin and is a factor in diabetes and hypoglycemia, with significant reductions in insulin need after replacement of amalgam fillings and normalizing of blood sugar. A connection between mercury in vaccines and epilepsy has also been found.

It should be noted that both blood and hair mercury level have been found to not be highly correlated to exposure from mercury vapor, which is the most common exposure from mercury. Mercury vapor has an extremely short half-life in blood and rapidly crosses cell membranes in body organs where it is oxidizes into inorganic mercury and accumulates in the brain, heart, kidneys, and other locations. Thus, although elemental mercury exposures are typically greater than organic exposures, most mercury in the blood is organic. Likewise, hair mercury has been shown to be more highly correlated with organic mercury exposure than with inorganic. Hair test are affected by external mercury exposure in occupational exposures such as dental offices which typically have fairly high levels of mercury. Other measures of mercury such as stool, saliva, and urine have been found to be better measures of mercury for such cases. Urine contains mostly inorganic mercury, but becomes less reliable with long term chronic exposure due to cumulative damage to the urinary detox system. Urinary fractionated porphyrin test is a good test of metabolic damage that has occurred due to mercury of other toxics. The level and distribution of the six porphyrins measured indicates extent of damage as well as likely source of damage.

Hair levels have been found to be generally reliable indicators of recent environmental metal exposures other than mercury and to be better correlated with symptoms than blood test. Similarly, blood levels have been found to not reflect chronic or historic cadmium exposure since metals, such as cadmium and mercury, have extremely short half-life in the blood but long half-life in the body. Air measurements of cadmium or mercury tend to be very unreliable due to the small particle size, dispersion variation, and other factors. Measure of accumulation in area plants is one reasonably reliable method; areas with cadmium levels over 0.5 ppm indicate significant air pollution.

Manganese can down-regulate serotonin function, reducing sociability and increasing aggressiveness or depression. Excess manganese exposure reduces dopamine levels, which can result in violent behavior. Higher levels of manganese exposure are correlated with Parkinson’s disease and violent behavior. The most common significant source of high manganese neonatal exposure is from soy infant formulas, which typically have very high levels of manganese.

Because lead and other toxic metals are retained in bone and astroglial cells in the brain, uptake during fetal development and early childhood has long-lasting effects on development and behavior. Among the toxic effects of lead is a reduction of dopamine function (which disturbs the behavioral inhibition mechanisms in the basal ganglia) and glutamate (which plays an essential role in the long term learning associated with the hippocampus). Research at the individual level showed that the uptake of heavy metals is associated with higher levels of learning disabilities, hyperactivity, substance abuse, violent crime, and other forms of anti-social behavior. In seven different samples of prison inmates, violent offenders had significantly higher levels of lead, cadmium, or manganese in hair than non-violent offenders or controls. In two studies (one measuring lead in blood, the other bone lead), high lead levels at age seven predicted juvenile delinquency and adult crime. A substantial proportion of individuals diagnosed with ADD/ADHD are likely to have dangerously high levels of lead, manganese, or cadmium in bodily tissues.

Children with blood lead levels of more than two micrograms per deciliter were four times more likely to have ADHD than children with levels below 0.8 microgram per deciliter. Because alcohol, cocaine, and other drugs temporarily restore neurotransmitter functions that are abnormal, substance abuse may often be crude self-medication in response to the effects of toxicity. Because lead down-regulates dopamine and cocaine is a non-selective dopamine reuptake inhibitor, lead toxicity could increase the risk of cocaine abuse.

Heavy metals compromise normal brain development and neurotransmitter function, leading to long-term deficits in learning and social behavior. At the individual level, earlier studies revealed that hyperactive children and criminal offenders have significantly elevated levels of lead, manganese, or cadmium compared to controls; high blood lead at age seven predicts juvenile delinquency and adult crime. At the environmental level, our research has found that environmental factors associated with toxicity are correlated with higher rates of anti-social behavior. For the period 1977 to 1997, levels of violent crime and teenage homicide were significantly correlated with the probability of prenatal and infant exposure to leaded gasoline years earlier. Across all U.S. counties for both 1985 and 1991, industrial releases of heavy metals were—controlling for over 20 socio-economic and demographic factors—also a risk-factor for higher rates of crime. Excess levels of lead and manganese are correlated with ADHD and violent behavior. Poor diet increases the effects of lead and manganese toxicity. Communities with a higher percentage of children having blood lead over 10 mg/dL are significantly more likely to have higher rates of violent crime and higher rates of educational failure. Studies comparing Toxic Release Inventory (TRI) data to crime rate data for all U.S. counties found a positive correlation between releases of lead and manganese and violent crime rates. Specialists at the Pfeiffer Treatment Center in Illinois have found that treatments to reduce levels of lead and other toxins provide lasting improvement without medication.

Surveys of children’s blood lead in Massachusetts, New York, and other states as well as NHANES III and an NIJ study of 24 cities point to another environmental factor: where silicofluorides are used as water treatment agents, risk-ratios for blood lead over 10ug/dL are from 1.25 to 2.5, with significant interactions between the silicofluorides and other factors associated with lead uptake. Communities using silicofluorides also report higher rates of learning disabilities, ADHD, violent crime, and criminals who were using cocaine at the time of arrest. The use of fluosilicic acid (H2SiF6) to fluoridate public water supplies significantly increases the amounts of lead in the water, whereas the use of sodium silicofluoride (NaSiF6) or sodium fluoride (NaF) does not. Communities using either fluosilicic acid (H2SiF6) or sodium silicofluoride (NaSiF6) have significantly higher rates of crime than those using sodium fluoride or delivering non-fluoridated water. Also where silicofluorides are in use, criminals are more likely to consume alcohol, more likely to have used cocaine at time of arrest. For 105 New York communities, for every age and racial group there was a significant association between silicofluoride treated community water and elevated blood lead. Data from analysis of national sample of over 4,000 children in NHANES III shows that water fluoridation is associated with a significant increase in children’s blood lead (with especially strong effects among minority children).

Sources of Exposure to Toxic Metals

The studies reviewed suggest that exposure to toxic metals may account for over 20% of learning disabilities, 20% of all strokes and heart attacks, and over 40% of all birth defects (in some areas). The U.S. Center for Disease Control has found that primary exposure to lead is from:

  • soil,
  • paint chips,
  • drinking water,
  • fertilizer,
  • food,
  • auto and industrial emissions,
  • ammunition (shot and bullets),
  • bathtubs (cast iron, porcelain, steel),
  • batteries,
  • canned foods,
  • ceramics,
  • chemical fertilizers,
  • cosmetics,
  • dolomite,
  • dust,
  • foods grown around industrial areas,
  • gasoline,
  • hair dyes and rinses,
  • leaded glass,
  • newsprint and colored advertisements,
  • paints,
  • pesticides,
  • pewter,
  • pottery,
  • rubber toys,
  • soft coal,
  • baby formula using tap water,
  • tobacco smoke, and
  • vinyl “mini-blinds.”

High levels of cadmium are found in regions with high emissions from incinerators, coal plants, or cars, as well as in shellfish, art supplies, bone meal and cigarette smoke. Other common sources include:

  • rural drinking water wells,
  • processed food,
  • fertilizer,
  • old paint,
  • food (coffee, fruits, grains, and vegetables grown in cadmium-laden soil, meats, or refined foods),
  • freshwater fish,
  • fungicides,
  • highway dusts,
  • incinerators,
  • mining,
  • nickel-cadmium batteries,
  • oxide dusts,
  • paints,
  • phosphate fertilizers,
  • power plants,
  • seafood (crab, flounder, mussels, oysters, scallops),
  • sewage and industrial sludge spread on farmland,
  • “softened” water,
  • smelting plants,
  • tobacco and tobacco smoke, and
  • welding fumes.

Since the half-life of lead in the blood is only 25 days, blood tests are not a reliable test for lead body burden. Hair element test is another option.

Common exposures to aluminum include aluminum cookware, antiperspirants, processed cheese and other processed food, lipstick, medications and drugs (anti-diarrheal agents, hemorrhoid medications, and vaginal douches), “softened” water, and tap water. Common sources of arsenic include antibiotics given to commercial livestock, air pollution, chemical processing, coal-fired power plants, defoliants, drinking water, drying agents for cotton, fish and shellfish, herbicides, insecticides, meats (from commercially raised poultry and cattle), metal ore smelting, pesticides, seafood (fish, mussels, oysters), specialty glass, and wood preservatives. Nickel, which is highly toxic and commonly causes immune reactions, is commonly seen in dental crowns and braces, along with jewelry, etc. Nickel and inorganic mercury commonly produce allergic type autoimmune problems. Manganese and other metal exposure can come through welding or metal work as well as from soy milk and soy products. Cadmium, mercury, arsenic, chromium, silver, copper, and are other metals to which Floridians and others are commonly exposed in drinking water, food, or dental materials. Some of the toxic metals in food come from land spreading of sewage and industrial waste on farmland.

The most common significant exposure for most people is to mercury vapor from amalgam fillings. Most people with several amalgam fillings have daily exposure exceeding the U.S. government health guideline for mercury. Likewise a major exposure source of infants and young children is from placental transfer from their mother’s amalgam fillings and breast feeding. The average amalgam filling has more than ½ gram of mercury and has been documented to continuously leak mercury into the body of those with amalgam fillings due to the low mercury vapor pressure and galvanic current induced by mixed metals in the mouth. Because of the extreme toxicity of mercury, only ½ gram is required to contaminate the ecosystem.

Mercury is one of the most toxic substances commonly encountered, and according to government agencies, causes adverse health effects in large numbers of people in the U.S. Based on widespread tests, the U.S. CDC estimates that approximately 10 % of women of childbearing age have current mercury levels that would put fetuses at risk of developmental neurological problems, without considering other common sources of mercury in infants. The extreme toxicity of mercury can be seen from documented effects on wildlife by very low levels of mercury exposure. The amount of mercury in the marine environment is increasing 4.8% per year, doubling every 16 years.

Some Florida panthers that eat birds and animals that eat fish containing very low levels of mercury (about 1 part per million) have died from chronic mercury poisoning. Since mercury is an estrogenic chemical and reproductive toxin, the majority of the rest cannot reproduce. The average male Florida panther has higher estrogen levels than females, due to the estrogenic properties of mercury. Similar is true of some other animals at the top of the food chain like polar bears, beluga and orca whales, and alligators, which are affected by mercury and other hormone disrupting chemicals.

Another major exposure source to infants is from thimerosal used in vaccinations as a preservative. The majority of infants get exposure above government health guidelines for mercury and large numbers of infants with related neurological problems such as autism and ADD have been documented. A major source of phenyl mercury is from mercury in paint, where many have been exposed to dangerous levels. The major source of exposure to methylmercury is from fish and shellfish, but inorganic mercury has also been found to be methylated in the body by bacteria, yeast, etc. Significant levels of various forms of organic mercury have also been documented from dental work such as root canals and gold crowns over amalgam base. Methylmercury has been documented to be among the most potent developmental neurotoxins, and evidence suggests that over 63,000 children are born each year with neurodevelopmental impairment due to prenatal exposure. Mercury vapor is the form that most readily crosses cellular membranes, including the blood-brain barrier and placenta of pregnant women, and results in the highest levels in the major organs such as the brain, heart, and kidneys for a given level of exposure. But the average half-life of vapor in the blood is only seconds so blood tests are not a good measure of such exposure. For similar reasons, hair mercury is a less accurate measure of body inorganic mercury burden than for the other metals. Both mercury vapor and organic mercury have been found to be highly toxic and to have independent and synergistic effects at very low levels. However, developmental effects have been found at comparable or lower levels from mercury vapor than from organic or inorganic exposure, and it has been well established that the primary exposure for most people is from mercury vapor from dental amalgam.

Measures to Reduce or Alleviate Toxic Metal Toxicity and Behavioral Problems

The most important measure to alleviate effects of toxic metals is avoidance of exposure or reducing current exposures. Significant improvement is usually seen after correcting digestive problems, eliminating allergens and environmental toxins, and improving nutrition. Treatment centers around the following goals: improvement of GI function, restoration of normal immune function, elimination of heavy metals and other toxins, and supplementation to optimize hepatic, immunologic, neurologic, and cognitive function.

Chelation is the most effective component of treatment, showing significant improvement in most patients. Chelators such as DMSA are often used or spirulina or chlorella based products. This is supported by selenium, milk thistle (silimarin), NAC (starting with low dose of 25 mg/day increasing to 200 mg/day), calcium-D-glucarate, Alpha-ketoglutarate (for those with high ammonia), taurine (100 mg to 1000 mg), methionine (100 to 400 mg), plant based enzymes, GC free diet, omega-3 EFAs, probiotics, vitamins A, C, and E, beta carotene, B complex and magnesium, zinc and multiminerals. Also pycogenol, L-theanine for calming effect and CoQ10, L-carnatine, L-carnosine, and DMAE for improved cognitive function. Iron deficiency can also be a factor in ADHD.

Blood hypercoagulation has been found to be a factor in some cases of adult ADHD, with herbs such as curcumin, ginger, and ginkgo biloba found to be beneficial in treatment. Structural studies show that some children with ADHD have decreased blood flow and energy use in the prefrontal cortex and striatum, which can also result in a decrease in brain volume of certain brain areas such as the areas related to attention. There can also be left hemispheric white matter deficits due to demyyelination and gray matter deficits in the right hemisphere. The drug Ritalin has been found to have an effect similar to the herbs discussed here in increasing regional cerebral brain flow in these areas, but unlike the herbs, Ritalin has also been found to commonly have long term adverse health effects.

Current exposure levels of most common metals can be tested by a stool test kit from a lab such as Doctors Data Lab or Genova Diagnostic Lab, and recent exposures can be tested somewhat easier and cheaper by hair tests. Research information on common causes of chronic conditions and treatment information can be found on the Genova Diagnostic Lab website.

Most infants prior to 2003 were exposured to mercury beyond the federal government health guideline from mercury thimerosal used as a preservative in vaccinations. Since all vaccinations are now available mercury free, parents should request the mercury free version. Significant levels are also received through placental transfer and breast feeding by mothers exposed to mercury through amalgam dental fillings or eating fish. Children with amalgam fillings get significant mercury exposure daily from their fillings, and replacement reduces daily exposure level approximately 90%.

Over 70% of mercury in the blood is commonly organic mercury, while the majority in the kidneys and urine is inorganic. The majority of exposure from amalgam is to vapor which rapidly is transmitted to cells throughout the body in blood and transformed to inorganic mercury in cells. There is common conversion in the body between organic and inorganic mercury through methylation and demethylation processes, so the type of mercury in the body does not indicate the original source of mercury.

For children with developmental or neurological conditions, a hair test can be used to assess toxic metal body burden. Urine fractionated porphyrin test can be used to assess metabolic effects. High levels of metals can be reduced by avoidance, replacement of metal dental work, use of mineral antagonists, oral chelators, and chemical chelation. Likewise, the majority of those with amalgam fillings have significant daily exposures often exceeding government health standards for mercury. Daily inorganic mercury exposure can be assessed by stool or saliva test or mouth oral air measurement, but since many have been tested, several studies have developed analytical equations to estimate daily exposure based on number of amalgam surfaces in the mouth, which give reasonable estimates. The main way to reduce mercury exposure to elemental mercury is to avoid amalgam fillings and/or replace amalgam fillings by other materials. Other materials are available that perform as well as amalgam.

Seafood and fish have often been found to have high levels of organic mercury, cadmium, and arsenic. For those eating significant amounts of such, the levels in the diet can be monitored by direct food testing or stool test for current exposure levels, or by hair or blood test. Fish and seafood from areas known to contain high levels of toxic metals should be eaten only occasionally if at all, depending on levels. Those who eat a lot of freshwater fish or seafood often have levels of mercury or some other metal exceeding government guidelines. Hair tests offer a reasonable reliable low cost method of assessing the level of many toxic metals in one test. In a large national survey, over 22% of those tested had dangerous levels of mercury. Aluminum exposures can be reduced by avoiding aluminum antiperspirants, food cooked in aluminum cookware, and foods such as processed cheese that have high levels of aluminum.

As previously noted one of the main mechanisms of toxic effects is generation of free radicals and oxidative damage. This can be partially alleviated by eating foods high in antioxidants or supplementation of vitamins A, C, and E, along with such as grape seed extract, pinebark extract, bilberry, etc. Bioflavinoids like bilberry and other fruits have been found to improve the function of the blood brain barrier. Vitamin C provides protection against toxicity of inorganic mercury by reducing the more toxic Hg2+ form to the less toxic Hg+ form of mercury. Vitamin B complex is also important to alleviate neurological effects. Most toxic metals also have mineral antagonist known to counteract toxic effects. For example selenium and zinc are antagonists of mercury, while zinc and iron are antagonists of cadmium. Iron and zinc deficiencies, which can be caused by exposure to toxic metals, increase metal toxicities and supplementation can reduce toxicities, but they can also be toxic if levels are too high. Likewise calcium and magnesium deficiencies and imbalances have been seen to be caused by toxic metals, and proper supplementation can reduce toxicities and reverse conditions caused by these deficiencies or imbalances. Several studies have found that most children with ADHD have deficiencies of certain minerals that are commonly depleted by exposure to toxic metals, such as magnesium and zinc, and most show significant improvement after supplementation with these minerals. Magnesium is the most common significant mineral deficiency among ADHD children, but zinc is commonly deficient among children with ADHD and disruptive behavior disorder.

Studies have found the level of free fatty acids also significantly lower in children with ADHD, and some practitioners recommend supplementation of essential fatty acids as well in treatment of ADHD. Large studies in schools in New York have found that dietary improvements and supplementation leads to large improvements in cognitive scores and large reductions in learning-disabled children.

Whey protein and N-acetylcysteine (NAC) can increase levels of glutathione, which is necessary for detoxification and is depleted by toxic metals. However care must also be exercised regarding proper level if these are supplemented, starting with low levels. Ensuring adequate calcium intake can reduce the toxic effects of lead. Chelation with chemical chelators such as DMSA can also greatly reduce metal body burden, but should only be considered with advice of a knowledgeable physician. DMSA (or EDTA) are effective for lead detoxification, but DMSA is also effective for mercury and other toxic metals. Studies have found that use of EDTA by patients with high levels of mercury can cause serious side effects, so EDTA should be used only when mercury levels have been found to be low or after reductions in mercury level using other means. DMPS is the most effective chelator for mercury body burden, but there have been some adverse effects that may be related to improper protocols. NAC, which can be obtained from most health food stores or catalogs, chelates mercury and arsenic but at a slower rate than the prescriptive chelators. Large numbers of children with ADD, autism, and other forms of learning disabilities have shown significant improvement after chelation and nutritional supplementation for deficiencies. Common deficiencies found to also be a factor in such conditions are Omega-3 fatty acid, vitamin B-6, lithium, zinc, iodine, and magnesium. In most clinics treating these conditions, the majority improved after treatment.

Since metal toxicity causes hormonal imbalances and problems, tests for hormone levels of thyroid hormones, DHEA, cortisol, etc. are available and supplementation for such has been found effective for conditions such as ADHD. Other supplements that clinical studies have found often effective for ADHD include EFAs (DHA/EPA), phosphatidylserine, choline, DMAE, L-glutamine, B vitamins, magnesium, zinc, curcumin, sprirulina, DHEA, iodine, and ginkgo biloba.

Avoidance of sugar and food allergens, such as wheat gluten and milk casein, as well as regular exercise have also been found to be beneficial in treatment of ADHD. Physical activity has been found to help kids who may be restless or hyperactive or who have been diagnosed with ADHD. Even emotional disturbances can be improved with exercise, as the activity provides an outlet for their energy and reduces the natural inclination of children to “act out.” Use of exercise therapy was found to have significant benefits. Exercise at school was also found to significantly increase reading and math ability of students, in addition to helping control obesity.


1. Nriagu JO. Global metal pollution: Poisoning the biosphere. Environment. 1990; 32(7).

2. Shukla GS, Singhal RL. The present status of biological effects of toxic metals in the environment: lead, cadmium, and manganese. Can J Physiol Pharmacol. 1984; 62(8): 1015-31.

3. Goyer RA.Toxic and essential metal interactions. Annu Rev Nutr. 1997; 17: 37-50.

4. Goyer RA, et al. Environmental risk factors for osteoporosis. Environ Health Perspect. 1994; 102(4): 390-394.

5. Lindh U, Carlmark B, Gronquist SO, Lindvall A. Metal exposure from amalgam alters the distribution of trace elements in blood cells and plasma. Clin Chem Lab Med. 2001; 39(2): 134-142.

6. Marlowe M, Cossairt A, Moon C. Errera J. Main and interactive effects of metallic toxins on classroom behavior. Journal of Abnormal Child Psychology. 1985; 13(2): 185-98.

7. Marlowe M, Stellern J, Errera J, Moon C. Main and interaction effects of metal pollutants on visual-motor performance. Arch Environ Health. 1985; 40(4): 221-5.

8. Pihl RO, Parkes M. Hair element content in learning disabled children. Science. 1977; 198(4313): 204-6.

9. Lewis M, Worobey J, Ramsay DS, McCormack MK. Prenatal exposure to heavy metals: effect on childhood cognitive skills and health status. Pediatrics. 1992; 89(6.1): 1010-15.

10. Capel ID, Pinnock MH, Dorrell HM, Williams DC, Grant EC. Comparison of concentrations of some trace, bulk, and toxic metals in the hair of normal and dyslexic children. Clin Chem. 1981; 27(6): 879-81.

11. Frith CD, et al. Dyslexia more common in English speaking countries. Science. 2001.

12. Marlowe M, Errera J, Jacobs J. Increased lead and cadmium burdens among mentally retarded children and children with borderline intelligence. Am J Ment Defic. 1983; 87(5): 477-83.

13. Thatcher RW, Lester ML, McAlaster R, Horst R. Effects of low levels of cadmium and lead on cognitive functioning in children. Arch Environ Health. 1982; 37(3): 159-66.

14. Marlowe M, Errera J, Cossairt A, Welch K. Hair mineral content as a predictor of learning disabilities. Journal of Learning Disabilities. 1985.

15. Marlowe M, Errera J, Jacobs J. Increased lead and mercury levels in emotionally disturbed children. Journal of Orthomolecular Psychiatry. 1983;12: 260-267.

16. Reston Va, Chislom J. Toxicity from heavy metal interactions and behavioral effects. Pediatrics. 1974; 53: 841-43.

17. Wecker L, Miller SB, Cochran SR, Dugger DL, Johnson WD. Trace element concentrations in hair from autistic children. Defic Res. 1985; 29(1): 15-22.

18. Rimland B, Larson GE. Hair mineral analysis and behavior: An analysis of 51 studies. Journal of Learning Disabilities. 1983; 16: 279-85.

19. Jiang HM, Han GA, He ZL. Clinical significance of hair cadmium content in the diagnosis of mental retardation of children. Chin Med J (Engl). 1990; 103(4): 331-4.

20. Emory E, Pattillo R, Archibold E, Bayorh M, Sung F. Neurobehavioral effects of low-level lead exposure in human neonates. Am J Obstet Gynecol. 1999; 181: S2-11.

21. Mendelsohn AL, Dreyer BP, et al. Low-level lead exposure and behavior in early childhood. Pediatrics. 1998; 101(3): E10.

22. Bonithon-Kopp C, Huel G, Moreau T, Wendling R. Prenatal exposure to lead and cadmium and psychomotor development of the child at 6 years. Neurolbehav Toxicol Teratol. 1986; 8(3): 307-10.

23. Leviton A, Bellinger D, Allred EN. Pre- and postnatal low-level lead exposure and children’s dysfunction in school. Environ Res. 1993; 60(1): 30-43.

24. Eppright TD, Samfacon JA, and Horwitz EA. ADHD, infantile autism, and elevated blood level: A possible relationship. Mo Med. 1996; 93(3): 136-8.

25. Brockel BJ, Cory-Slechta DA. Lead, attention, and impulsive behavior. Pharmacol Biochem Behav. 1998; 60(2): 545-52.

26. Bellinger D, et al. Attentional correlates of dentin levels in adolescents. Arch Environ Health. 1994; 49(2): 8-105.

27. Rice DC. Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys. Environ Health Perspect. 2000; 108(3).

28. Needleman HL, McFarland C, Ness RB, Fienberg SE, Tobin MJ. Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol. 2002; 24(6): 711-7.

29. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent behavior. JAMA. 1996; 275(5): 363-9.

30. Needleman H. Lead exposure and delinquency. Neurotoxicol Teratol. 2003.

31. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low dose of lead in childhood. N. Eng J Med. 1990; 322: 83-88.

32. Needleman HL, Leviton A, Reed R. Deficits in psychological and classroom performance of children with elevated dentine lead levels. New Eng J Med. 1979; 300: 689-95.

33. Burns JM, Baghurst PA, Sawyer MG, McMichael Am, Ton SL. Lifetime low-level lead exposure to environmental lead and children’s emotional and behavioral development at ages 11-13. Am J Epidemiology. 1999; 149(8): 740-49.

34. Winneke G, Kramer U, et al. Neurolpsychological studies in children with elevated tooth lead. International Archives of Occupational Environmental Health. 1983; 51: 231-252.

35. de la Burde B, Dhoate M. Early asymptomatic lead exposure and development at school age. Journal of Pediatrics. 1975; 87: 638-642.

36. He Y, Yang X, Xu F. Application of Conners Rating Scales in the study of lead exposure and behavioral effects in children. Zhonghua Yu Fang Yi Xue Za Zhi. 2000; 34(5): 290-3.

37. Canfield R, et al. Lead levels below federal standard causes IQ drop. N Eng J Med. 2003; 348(16): 1517-26.

38. Annau Z, Cuomo V. Mechanisms of neurotoxicity and their relationship to behavioral changes. Toxicology. 1988; 49(2-3): 219-25.

39. Needleman HL. Behavioral Toxicology. Environ Health Perspect. 1995; 103(6): 77-79.

40. Abadin HG, Hibbs BF, Pohl HR. Breast-feeding exposure of infants to cadmium, lead, and mercury: a public health viewpoint. Toxicol Ind Health. 1997; 13(4): 495-517.

41. Boadi WY, Urbach J, Branes JM, Yannai S. In vitro exposure to mercury and cadmium alters term human placental membrane fluidity. Pharmacol. 1992; 116(1): 17-23.

42. Semczuk M, Semczuk-Sikora A. New data on toxic metal intoxication (Cd, Pb, and Hg in particular Mg) status during pregnancy. Med Sci Monit. 2001; 7(2): 332-340.

43. Stewart-Pinkham, SM. The effect of ambient cadmium air pollution on the hair mineral content of children. The Science of the Total Environment. 1989; 78: 289-96.

44. Stejskal VDM, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A, et al. Metal-specific memory lymphocytes: biomarkers of sensitivity in man. Neuroendocrinology Letters. 1999.

45. Tibbling L, Stejskal VDM, et al. Immunological and brain MRI changes in patients with suspected metal intoxication. Int J Occup Med Toxicol. 1995; 4(2): 285-294.

46. Stejskal VDM, et al. MELISA: Tool for the study of metal allergy. Toxicology in Vitro. 1994; 8(5):991-1000.

47. Clarkson TW, et al. Reproductive and developmental toxicity of metals. Scandinavian J. of Work & Environmental Health. 1985; 11:145-154.

48. Anderson HA, Wolff MS. Environmental contaminants in human milk. J Expo Anal Environ Epidemiol. 2000; 10(6.2): 755-60.

49. Lutz E, Lind B, Herin P, Krakau I, Bui TH, Vahter M. Concentrations of mercury, cadmium, and lead in brain and kidney of second trimester fetuses and Infants. Journal of Trace Elements in Medicine and Biology. 1996; 10: 61-67.

50. Drasch G, et al. Mercury burden of human fetal and infant tissues. Eur J Pediatr. 1994; 153: 607-610.

51. Oskarsson, et al. Mercury in breast milk in relation to fish consumption and amalgam. Arch Environ Health. 1996; 51(3): 234-41.

52. Drasch, et al. Mercury in human colostrum and early breast milk. Journal of Trace Elements in Medicine and Biology. 1998; 12: 23-27.

53. Vahter M, Akesson A, Lind B, Bjors U, Schutz A, Berglund M. Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. Environ Res. 2000; 84(2):186-94.

54. Ramirez GB, Cruz CV, Dalisay C. The Tagum Study I: Analysis and clinical correlates of mercury in maternal and cord blood, breast milk, meconium, and infants’ hair. Pediatrics. 2000; 106(4): 774-781.

55. Facemire CF, et al. Reproductive impairment in the Florida panther. Environ Health Perspect. 1995; 103(4): 79-86.

56. Gerhard, et al. The limits of hormone substitution in pollutant exposure and fertility disorders. Zentralbl Gynakol. 1992; 114: 593-602.

57. Ryan PB, et al. Exposure to arsenic, cadmium, and lead in drinking water. Environ Health Perspect. 2000; 108(8).

58. Casdorph HR. Toxic Metal Syndrome. Avery Publishing Group; 1995.

59. Muldoon SB, et al. Effects of lead levels on cognitive function of older women. Neuroepidemiology. 1996; 15(2): 62-72.

60. Neddleman HL, et al. The long-term effects of exposure to low doses of lead in childhood. N Eng J Med. 1990; 322(2): 83-8.

61. Smith M. Woman’s poison fillings blamed for attack on mother. The Daily Telegraph. 1998: 14.

62. Atchison WD. Effects of neurotoxicants on synaptic transmission: lessons learned from electrophysiological studies. Neurotoxicol Teratol. 1988; 10(5): 393-416.

63. Bulat P. Activity of Gpx and SOD in workers occupationally exposed to mercury. Arch Occup Environ Health. 1998; 71: S37-9.

64. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995; 18(2): 321-36.

65. Lopez-Ortal P, Souza V, Bucio L, Gonzalez E, Gutierrez-Ruiz M. DNA damage produced by cadmium in human fetal hepatic cell line. Mutat Res. 1999; 439(2): 301-6.

66. Rodier PM. Developing brain as a target of toxicity. Environ Health Perspect. 1995; 103(6): 73-76.

67. Weiss B, Landrigan PJ. The developing brain and the environment. Environ Health Perspect. 2000; 107(3).

68. Frith CD, et al. More dyslexia in English speaking countries. Science. 2001.

69. Stein J, Schettler T, Wallinga D, Valenti M. In harm’s way: Toxic threats to child development. J Dev Behav Pediatr. 2002; 23(1): S13-22.

70. Rice, DC. Issues in developmental neurotoxicology: Interpretation and implications of the data. Can J Public Health. 1998; 89(1): S31-40.

71. Rice DC, Barone S. Critical periods of vulnerability for the developing nervous system: Evidence from human and animal models. Environ Health Persect. 2000; 108(3): 511-533.

72. Singhal RL, Merali Z. Aspects of the biochemical toxicity of cadmium. Biochem Aspec Toxic Agents. 1979; 35: 75-80.

73. Underwood EJ. Trace Elements in Nutrition. New York: New York Academic Press; 1997.

74. Earl C, Chantry A, Mohammad N. Zinc ions stabilize the association of basic protein with brain myelin membranes. J Neurochem. 1988; 51: 718-24.

75. Ricco P, Giovanneli S, Bobba A. Specificity of zinc binding to myelin basic protein. Neurochem Res. 1995; 20: 1107-13.

76. Spivey-Fox MR. Nutritional influences on metal toxicity. Environ Health Perspect. 1979; 29: 95-104.

77. Pfeiffer SI, et al. Efficacy of vitamin B6 and magnesium in the treatment of autism. J Autism Dev Disord. 1995; 25(5): 481-93.

78. Govani S, Memo M. Chronic lead treatment differentially affects dopamine synthesis. Toxicology. 1979; 12: 343-49.

79. Scheuhammer AM, Cherian MG. Effects of heavy metal cations and sulfhydyl reagents on striatal D2 dopamine receptors. Biochem Pharmacol. 1985; 34(19): 3405-13.

80. Bouchard MF, van Wijngaarden. Major depressive disorder and panic disorder related to lead exposure. Arch Gen Psychiatry. 2009; 66: 1313-1319.

81. Maizlish NA, Parra G, Feo O. Neurobehavioural evaluation of Venezuelan workers exposed to inorganic lead. Occup Environ Med. 1995; 52(6): 408-14.

82. Camara DD, et al. Methodology to prevent mercury exposure among adolescents from goldmine areas in Brazil. Cad Saude Publica. 1996; 12(2): 149-158.

83. Wang X, Bowdler NC, Beasley DS. Behavioral effects of aluminum ingestion. Pharmacol Biochem Behav. 1979; 10: 505-512.

84. Dietrich KN, Berger OG, Succop PA. The developmental consequences of low to moderate postnatal lead exposure. Neurotoxicol Teratol. 1993; 15(1): 37-44.

85. Tong S, Baghurst P, McMichael A, Sawyer M. Lifetime exposure to lead and children’s intelligence at 11-13 years: Port Pirie cohort study. BMJ. 1996; 312(7046): 1569-75.

86. Frery N, et al. Validity of hair cadmium in detecting chronic cadmium exposure in general populations. Bulletin of Environ Contamination. 1993; 501: 736-43.

87. Frery N, et al. Environmental exposure to cadmium and human birth weight. Toxicology. 1993; 79(2):109-18.

88. Huel G, et al. Cadmium and lead content of maternal and newborn hair: Relationship to party, birth, and hypertension. Arch Environ Health. 1981; 36(5): 221-7.

89. Huel G, et al. Increased hair cadmium in hair of newborns of women occupationally exposed to heavy metals. Environ Res. 1984; 35(1): 115-21.

90. Bergomi M, et al. Blood, teeth, and hair: evaluation of exposure to lead and cadmium in children living in an industrial zone. Ann Ig. 1989; 1(5): 1185-96.

91. Vivoli G, et al. Cadmium in blood, urine, and hair related to human hypertension. J Trace Elem Electrolytes Health Dis. 1989; 3(3): 139-45.

92. Hart RP, et al. Neuropsychological effects of occupational exposure to cadmium. J Clin Exp Neuropsychol. 1989; 11(6): 933-43.

93. Petit TL, et al, Early lead exposure and the hippocampus. Neurotoxicology. 1983; 4(1): 74-79.

94. Raghunath R, et al. Retention times of Pb, Cd, and Zn in children’s blood. Sci Total Environ. 1997; 207(2-3): 133-9.

95. Zhuang GS, Wang YS, Tan MG, Zhi M, Pan WQ, Cheng YD. Preliminary study of the distribution of the toxic elements As, Cd, and Hg in human hair and tissues by NAA. Biol Trace Elem Res. 1990: 729-36.

96. Nielsen FH, et al. Nickel deficiency in rats. J Nutr. 1975; 105(12):1620-30.

97. Smith SA, et al. Elevated serum nickel concentration in psoriasis vulgaris. In J Dermatol. 1994; 33(11): 783-5.

98. Messer RLW, et al. An investigation of fibroblast mitochondria enzyme activity and respiration in response to metallic ions released from dental alloys. J Biomed Mater Res. 2000; 50: 598-604.

99. Hu H. Knowledge of diagnosis and reproductive history among survivors of childhood plumbism. Am J Public Health. 1991; 81(8): 1070-2.

100. Lutz PM, et al. Elevated immunoglobulin E (IgE) levels in children with exposure to environmental lead. Toxicology. 1999; 134(1): 63-78.

101. Gottschalk LA, et al. Abnormalities in hair trace elements as indicators of aberrant behavior. Compr Psychiatry. 1991; 32(3): 229-37.

102. Nevin R. How lead exposure relates to temporal changes in IQ, violent crime, and unwed pregnancy. Environ Res. 2000; 83(1): 1-22.

103. Stretesky PB, Lynch MJ. The relationship between lead exposure and homicide. Arch Pediatr Adolesc Med. 2001; 155(5): 579-82.

104. Schauss AG. Comparative hair mineral analysis in a randomly selected “normal” population and violent criminal offenders. Int J Biosocial Res. 1981; 1: 21-41.

105. Pihl RO, Ervin F. Lead and cadmium levels in violent criminals. Psychol Rep. 1990; 66(3.1): 839-44.

106. Cromwell PF, et al. Hair mineral analysis: biochemical imbalances and violent criminal behavior. Psychol Rep. 1989; 64: 259-66.

107. Fox MR, Jacobs Rm, Jones AO, Fry Be Jr, Stone CL. Effects of Citamin C and Iron on cadmium metabolism. Ann N Y Acad Sci. 1980; 355: 249-61.

108. Geertz R, Gulyas H Gercken G. Cytotoxicity of dust constituents to alveolar machrophages: Interactions of heavy metal compounds. Toxicology. 1994; 86(1-2): 13-27.

109. Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev. 1998; 3(4): 262-70.

110. Life Enhancement. http://www.life-enhancement.com/

111. Kozielec T, Starobrat-Hermelin B. Assessment of magnesium levels in children with ADHD. Magnes Res. 1997; 10(2): 143-8.

112. Starobrat-Hermelin B. The effect of deficiency of selected bioelements on hyperactvity in children with certain specified mental disorders. Ann Acad Med Stetin. 1998; 44: 297-314.

113. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with ADHD: Positive response to magnesium oral loading test. Magnes Res. 1997; 10(2): 149-56

114. Mousain-Bosc M, Roche M, Rapin J, Bali JP. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr. 2004; 23(5): 545.

115. Rasmussen HH, Mortensen PB, Jensen IW. Depression and magnesium deficiency. Int J Psychiatry Med. 1989; 19(1): 57-63.

116. Bekaroglu M, Aslan Y, Gedik Y, Karahan C. Relationships between serum free fatty acids and zinc with ADHD. J Child Psychol Psychiatry. 1996; 37(2): 225-7.

117. Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry. 1997; 42(5): 349-358.

118. Arnold LE, Votolato NA, Kleykamp D, Baker GB, Bornstein RA. Does hair zinc predict treatment improvement of ADHD? Int J Neurosci. 1990; 50(1-2):103-7.

119. Haglund B, Ryckenberg K, Selinus O, Dahlquist G. Evidence of a relationship between childhood-onset diabtes and low groundwater concentration of zinc. Diabetes Care. 1996; 19(8): 873-5.

120. Shrestha KP, Oswaldo A. Trace elements in hair of epileptic and normal subjects. Sci Total Environ. 1987; 67 (2-3): 215-25.

121. Smith JB, Dwyer SD, Smith L. Cadmium evokes inositol polyphosphate formation and calcium mobilization: Evidence for a cell surface receptor that cadmium stimulates and zinc antagonizes. J Biol Chem. 1989; 264(13): 7115-8.

122. Nonaka S, et al. Lithium treatment protects neurons in CNS from glutamate induced excitability and calcium influx. Neurobiology. 1998; 95(5): 2642-2647.

123. Endo T, Sakata M, Shaikh ZA. Mercury uptake by primary cultures of rat renal cortical epithelial cells. II. Effects of pH, halide ions, and alkali metal ions (potassium & lithium). Toxicol Appl Pharmacol. 1995; 134(2): 321-325.

124. Schrauzer GN, Shrestha KP, Flores-Arce MF. Lithium in scalp hair of adults, students, and violent criminals. Effects of supplementation and evidence for interactions of lithium with vitamin B12 and with other trace elements. Biol Trace Elem Res. 1992; 34(2):161-76.

125. Schrauzer GN, de Vroey E. Effects of nutritional lithium supplementation on mood. A placebo-controlled study with former drug users. Biol Trace Elem Res. 1994; 40(1): 89-101.

126. Spreat S, Behar D, Reneski B, Miazzo P. Lithium carbonate for aggression in mentally retarded persons. Compr Psychiatry. 1989; 30(6): 505-11.

127. Schrauzer GN, Shrestha KP. Lithium in drinking water and the incidences of crimes, suicides, and arrests related to drug addictions. Biol Trace Elem Res. 1990; 25(2):105-13.

128. Sheard MH, Marini JL, Bridges CI, Wagner E. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry. 1976; 133(12): 1409-13.

129. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: A novel form of mercury poisoning. Med Hyp. 2001; 56(4): 462.

130. Edelson SB, Cantor DS. Autism: Xenobiotic influences. Toxicol Ind Health. 1998; 14(4): 553-63.

131. Tuthill RW. Hair lead levels related to children’s classroom attention-deficit behavior. Arch Environ Health. 1996; 51(3): 214-20.

132. Naylor GJ, Corrigan FM, Smith AH, Connelly P, Ward NI. Further studies of vanadium in depressive psychosis. Br J Psychiatry. 1987; 150: 656-61.

133. Naylor GJ. Reversal of vanadate-induced inhibition of Na-K ATPase. J Affect Disord. 1985; 8(1): 91-3.

134. Naylor GJ, et al. Tissue vanadium levels in manic-depressive illness. Psychol Med. 1984; 14(4): 767-72.

135. Naylor, et al. Elevated vanadium content of hair and mania. Biol Psychiatry. 1984; 19(5): 759-64.

136. Simonoff M, Simonoff G, Conri C. Vanadium in depressive states. Acta Pharmacol Toxicol. 1986; 59(7): 463-6.

137. Sidransky H, Verney E. Influence of lead acetate and selected metal salts on tryptophan binding to rat hepatic nuclei. Toxicol Pathol. 1999; 27(4): 441-7.

138. Shukla GS, Chandra SV. Effect of interaction of Mn2+withZn2+, Hg2+, and Cd2+ on some neurochemicals in rats. Toxicol Lett. 1982; 10(2-3):163-8.

139. Brouwer M, et al. Functional changes induced by heavy metal ions. Biochemistry. 1982; 21(20): 2529-38.

140. Benkelfat C, et al. Mood lowering effect of tryptophan depletion. Arch Gen Psychiatry. 1994; 51(9): 687-97.

141. Young SN, et al. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology. 1985; 87(2): 173-77.

142. Smith KA, et al. Relapse of depression after depletion of tryptophan. Lancet. 1997; 349(9056): 915-19.

143. Delgado PL, et al. Serotonin function, depletion of plasma tryptophan, and the mechanism of antidepressant action. Arch Gen Psychiatry. 1990; 47(5): 411-18.

144. May M. Disturbing behavior: Neurotoxic effects in children. Environ Health Perspect. 2000; 108(6): A262-A267.

145. Barlow PJ. A pilot study on the metal levels in hair of hyperactive children. Med Hyp. 1983; 11(3): 309-18.

146. Pfieffer CC, Braverman ER. Zinc, the brain and behavior. Biol Psychiat. 1982; 17(4): 513-32.

147. Tejwani GA, Hanissian SH. Modulation of mu, delta, and kappa opioid receptors in rat brain by metal ions and histidine. Neuropharmology. 1990; 29(5): 445-52.

148. Mondal MS, Mitra S. Inhibition of bovine xanthine oxidase activity by Hg2+ and other metal ions. J Inorg Biochem. 1996; 62(4): 271-9.

149. Sastry KV, Gupta PK. In vitro inhibition of digestive enzymes by heavy metals and their reversal by chelating agents: Part 1, mercuric chloride intoxication. Bull Environ Contam Toxicol. 1978; 20(6): 729-35.

150. Boadi WY, et al. In vitro effect of mercury on enzyme activities. Environ Res. 1992; 57(1): 96-106.

151. McFadden SA. Phenotypic variation in xenobiotic metabolism and adverse environmental response: Focus on sulfur-dependent detoxification pathways. Toxicology. 1996; 111(1-3): 43-65.

152. Markovich, et al. Heavy metals (Hg,Cd) inhibit the activity of the liver and kidney sulfate transporter Sat-1. Toxicol App Pharmacol. 1999; 154(2): 181-7.

153. Takeuchi F, Otsuka H, Shibata Y. Effect of metal ions on kynureninase from rat liver. Acta Vitaminol Enzymol. 1981; 3(4): 224-30.

154. Shibuya-Saruta H, Kasahara Y, Hashimoto Y. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties. J Clin Lab Anal. 1996; 10(6): 435-40.

155. Blais A, Morvan-Baleynaud J, Friedlander G, Le Grimellec C. Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics. Kidney Int. 1993; 44(1):13-8.

156. Puschel G, Mentlein R, Heymann E. Isolation and characterization of dipeptidyl peptidase IV from human placenta. Eur J Biochem. 1982; 126(2): 359-65.

157. Kar NC, Pearson CM. Dipeptyl peptidases in human muscle disease. Clin Chim Acta. 1978; 82(1-2): 185-92.

158. Stefanovic V, et al. Kidney ectopeptidases in mercuric chloride-induced renal failure. Cell Physiol Biochem. 1998; 8(5): 278-84.

159. Crinnion WJ. Environmental toxins and their common health effects. Altern Med Rev. 2000; 5(1): 52-63.

160. Cade JR, et al. Autism and schizophrenia linked to malfunctioning enzyme for milk protein digestion. Autism. 1999.

161. Reichelt KL. Biochemistry and psycholphisiology of autistic syndromes. Tidsskr Nor Laegeforen. 1994; 114(12): 1432-4.

162. Reichelt KL, et al. Biologically active peptide-containing fractions in schizophrenia and childhood autism. Adv Biochem Psychopharmocol. 1981; 28: 627-43.

163. Lucarelli S, Cardi E, et al. Food allergy and infantile autism. Panminerva Med. 1995; 37(3):137-41.

164. Kurek M, Przybilla B, Hermann K, Ring JA. An opioid peptide from cows milk, beta-casomorphine-7, is a direct histamine releaser in man. Int Arch Allergy Immunol. 1992; 97(2): 115-20.

165. Willemsen-Swinkels SH, Buitelaar JK, Weijnen FG, Thisjssen JH, Van Engeland H. Plasma beta-endorphin concentrations in people with learning disability and self-injurious and/or autistic behavior. Br J Psychiary. 1996; 168(1): 105-9.

166. Leboyer M, Launay JM et al. Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autism. Am J Psychiatry. 1994; 151(12): 1797-1801.

167. Huebner FR, Lieberman KW, Rubino RP, Wall JS. Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides. 1984; 5(6): 1139-47.

168. Scifo R, Marchetti B, et al. Opioid-immune interactions in autism: behavioral and immunological assessment during a double-blind treatment with naltexone. Ann Super Sanita. 1996; 32(3): 351-9.

169. Eedy DJ, Burrows D, Dlifford T, Fay A. Elevated T cell subpopulations in dental students. J Prosthet Dent. 1990; 63(5): 593-6.

170. Yonk LJ, et al. CD+4 helper T-cell depression in autism. Immunol Lett. 1990; 25(4): 341-5.

171. Alberti A, PirroneP, Elia M, Waring RH, Romano C. Sulphation deficit in “low-functioning” autistic children. Biol Psychiatry. 1999; 46(3): 420-4.

172. Wakefield A, et al. Ileal-lymphoid-nodular hyperplasia and pervasive developmental disorder in children. Lancet. 1998; 351(9103): 637-41.

173. Wakefield A, et al. Inflammatory bowel disease syndrome and autism. Lancet. 2000.

174. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel and autism. Dig Dis Sci. 2000; 45(4): 723-9.

175. Singh VK, Lin SX, Yang VC. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol. 1998; 89(1):105-8.

176. Wang CH, Chen CJ, et al. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation. 2002; 105(15):1804-9.

177. Hopenhayn-Rich C, et al. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect. 2000; 108(7).

178. Knashawn H, et al. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect. 2000; 108(7).

179. Goyer RA, Toxic effects of metals. In: Casarett Doull, ed. Toxicology: The Basic Science of Poisons. 5th ed. New York: McGraw-Hill; 1996.

180. Grandjean P, Jurgensen PJ, Weihe P. Milk as a source of methylmercury exposure in infants: Milk as a source of methylmercury exposure in infants. Environ Health Perspect. 1994; 102(1): 74-7.

181. Burbacher TM, Rodier PM, Weiss B. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol. 1990; 3: 191-202.

182. Kostial K, et al. Decreased Hg retention with DMSA. J Appl Toxicol. 1993; 13(5): 321-5.

183. Lund ME, et al. Treatment of acute MeHg poisoning by NAC. J Toxicol Clin Toxicol. 1984; 22(1): 31-49.

184. Livardjani F, Ledig M, Kopp P, Dahlet M, Leroy M, Jaeger A. Lung and blood superoxide dismutase activity in mercury vapor exposed rats: Effect of N-acetylcysteine treatment. Toxicology. 1991; 66(3): 289-95.

185. Gregus Z, et al. Effect of lipoic acid on biliary excretion of glutathione and metals. Toxicol App Pharmacol. 1992; 114(1): 88-96.

186. Gurer H, Ozgunes H, Oztezcan S, Ercal N. Antioxidant role of lipoic acid in lead toxicity. Free Radic Biol Med. 1999; 27(1-2): 75-81.

187. Kerbeshian J, Burd L, Fisher W. Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomology. J Clin Psychopharmacology. 1987; 7(6): 401-5.

188. Tumuluru RV, Weller EB, Fristad MA,Weller RA. Mania in six preschool children. J Child Adolesc Psychopharmacol. 2003; 13(4): 489-94.

189. Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V. Plasma excitatory amino acids in autism. Invest Clin. 1996; 37(2):113-28.

190. Rolf LH, Haarman FY, Grotemeyer KH, Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand. 1993; 87(5): 312-6.

191. Naruse H, Hayashi T, Takesada M, Yamazaki K. Metabolic changes in aromatic amino acids and monoamines in infantile autism and a new related treatment. No To Hattatsu. 1989; 21(2): 181-9.

192. Carlsson ML. Is infantile autism a hypoglutamatergic disorder? J Neural Transm. 1998; 105(4-5): 525-35.

193. Agocs MM, Etzel RA, Parrish RG, Hesse JL. Mercury exposure from interior latex paint. N Engl J Med. 1990; 323(16): 1096-101.

194. Neilke HW, Reagan PL. Soil is an important pathway of human lead exposure. Environ Health Perspect. 1998, 106: 217-29.

195. Huggins HA, Levy TE. Uniformed Consent: The Hidden Dangers in Dental Care. Hampton Roads Publishing Company Inc.; 1999.

196. Soderstrom S, Fredriksson A, Dencker L, Ebendal T. The effect of mercury vapor on cholinergic neurons in the fetal brain. Brain Res & Dev Brain Res. 1995; 85: 96-108.

197. Miszta H, Dabrowski Z. Effect of mercury and combined effect of mercury on the activity of acetylcholinesterase of rat lymphocytes during in vitro incubation. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989; 116(1):151-5.

198. Bear D, Rosenbaum J, Norman R. Aggression in cat and human precipitated by a cholinesterase inhibitor. Journal Psychosomatics. 1986; 27(7): 535-536.

199. Devinsky O, Kernan J, Bear D. Aggressive behavior following exposure to cholinesterase inhibitors. Journal of Neuropsychiatry. 1992; 4(2): 189-199.

200. Porterfield SP. Thyroidal dysfunction and environmental chemicals: Potential impact on brain development. Environ Health Perspect. 2000; 108(3).

201. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: Implications for population screening. J Men Screen. 2000; 7(3):127-30.

202. Romani L. Immunity to candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol. 1999; 2(4): 363-7.

203. Zamm AV. Candida albicans therapy: Dental mercury removal, an effective adjunct. J. Orthmol. Med. 1986; 1(4): 261-5.

204. Edwards AE. Depression and candida. JAMA. 1985; 253(23): 3400.

205. Crook WG, Depression associated with candida albicans infections. JAMA. 1984; 251: 22.

206. Pfeiffer CC, Iliev V. A study of copper excess and zinc deficiency in schizophrenia. In: International Review of Neurobiology. Supp 1. New York: NY Academic Press; 1972: 141-164.

207. Alexander PE, Van Kammen DP. Serum magnesium and calcium levels in schizophrenia. Arch Gen Psychiatry. 1979; 36: 1372-77.

208. Walsh WJ, Isaacson Hr, Hall A. Elevated blood copper to zinc ratios in assaultive young males. Physiol Behav. 1997; 62(2): 327-9.

209. Mathieson PW. Mercury: God of TH2 cells. Clinical Exp Immunol. 1995.

210. Srikantaiah MV, Radhakrishnan AN. Studies on the metabolism of vitamin B6 in the small intestine: Part III–purification and properties of monkey intestinal pyridoxal kinase. Indian J of Biochem. 1970; 7:151-156.

211. Schauss A, Costin C. Zinc and Eating Disorders. Keats Publishing; 1989.

212. Lavie R. Iron and copper overload. Consumer Health Newsletter. 1998; 21(6).

213. Landner L, Lindestrom L. Copper in Society and the Environment. 2nd ed. Swedish Environmental Research Group (MFG); 1999.

214. Salzer HM. Relative hypoglycemia as a cause of neuropsychiatric illness. J National Med Assoc. 1996; 58(1): 12-17.

215. Heninger GR, et al. Depressive symptoms, glucose tolerance, and insulin tolerance. J Nervous and Mental Dis. 1975; 161(6): 421-32.

216. Winokur A, et al. Insulin resistance in patients with major depression. Am J Psychiatry. 1988; 45(3): 325-30.

217. Virkkunen M, Huttunen MO. Evidence for abnormal glucose tolerance among violent offenders. Neuropsychiobilogy. 1982; 8: 30-40.

218. Markku I, Virkkunen L. Aggression, suicidality, and serotonin. J Clinical Psy. 1992; 53(10): 46-51.

219. Linnoila M, et al. Low serotonin metabolite differentiates impulsive from non-impulsive violent behavior. Life Sciences, 1983; 33(26): 2609-2614.

220. Lopez-Ibor JJ. Serotonin and psychiatric disorders. Int Clinical Psychopharm. 1992; 7(2): 5-11.

221. Thomas DE, et al. Tryptophan and nutritional status in patients with senile dementia. Psychological Med. 1986; 16: 297-305.

222. Urberg M, Zemel MB. Evidence for synergism between chromium and nicotinic acid in the control of glucose tolerance in elderly humans. Metabolism. 1987; 36(9): 896-899.

223. Anderson RA, et al. Effects of supplemental chromium on patients with reactive hypoglycemia. Metabolism. 1987; 36(4): 351-355.

224. Mata L, Sanchez L, Calvo M. Interaction of mercury with human and bovine milk proteins. Biosci Biotechnol Biochem. 1997; 61(10):1641-5.

225. Kostial K, Rabar I, Ciganovic M, Simonovic I. Effect of milk on mercury absorption and gut retention in rats. Bull Environ Contam Toxicol. 1979; 23(4-5): 566-7.

226. Rowland IR, Robinson RD, Doherty RA. Effects of diet on mercury metabolism and excretion in mice given methylmercury: Role of gut flora. Arch Environ Health. 1984; 39(6): 401-8.

227. Camara VD, et al. Methodology to prevent mercury exposure among adolescents from goldmine areas in Mariana, state of Minas Gerais, Brazil. Cad Saude Publica. 1996; 12(2):149-158.

228. Bowler RM, Roels HA, et al. Manganese exposure: Neuropsychological and neurological symptoms and effects in welders. Neurotoxicology. 2005

229. Bowler RM, Mergler D, et al. Neuropsychiatric effects of manganese on mood. Neurotoxicology. 1999; 20(2-3): 367-78.

230. Tardiff K. Unusual diagnoses among violent patients. Psychiatr Clin North Am. 1998; 21(3): 567-76.

231. Lucchini R, Albini E, Placidi D, Alessio L. Mechanism of neurobehavioral alteration. Toxicol Lett. 2000; 112-113: 35-9.

232. Mergler D, Baldwin M, et al. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology. 1999; 20(2-3): 327-42.

233. Lucchini R, Apostoli P, et al. Long-term exposure to “low levels” of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology. 1999; 20(2-3): 287-97.

234. Woolf A, Wright R, Amarasiriwardena C, Bellinger D. A child with chronic manganese exposure from drinking water. Environ Health Perspect. 2002; 110 (6): 613-6.

235. Siblerud RL, et al. Psychometric evidence that mercury from dental fillings may be a factor in depression, anger, and anxiety. Psychol Rep. 1994; 74(1).

236. Hultman P, Johansson U, Turley SJ. Adverse immunological effects and autoimmunity induced by dental amalgam in mice. FASEB J. 1994; 8:1183-90.

237. Pollard KM, Lee DK, Casiano CA. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular structure ad antigenic properties. J Immunol. 1997; 158: 3421-8.

238. Bigazzi PL. Autoimmunity induced by metals. In: Chang L, ed. Toxicology of Metals. Lewis Publishers, CRC Press Inc; 1996: 835-52.

239. Hu H, Moller G, Abedi-Valugerdi M. Major histocompatibility complex class II antigens are required for both cytokine production and proliferation induced by mercuric chloride in vitro. J Autoimmun. 1997; 10(5): 441-6.

240. El-Fawai HA, Waterman SJ, De Feo A, Shamy MY. Neuroimmunotoxicology: Humoral assessment of neurotoxicity and autoimmune mechanisms. Contact Dermatitis. 1999; 41(1): 60-1.

241. Hu H, Moller G, Abedi-Valugerdi M. Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunology. 1999; 96(3): 348-57.

242. Veltman JC, et al. Alterations of heme, cytochrome P-450, and steroid metabolism by mercury in rat adrenal gland. Arch Biochem Biophys. 1986; 248(2): 467-78.

243. Riedl AG, et al. P450 and hemeoxygenase enzymes in the basal ganglia and their roles in Parkinson’s disease. Adv Neurol. 1999; 80: 271-86.

244. Aschner M, et al. Metallothionein induction in fetal rat brain by in utero exposure to elemental mercury vapor. Brain Res. 1997; 778(1): 222-32.

245. O’Halloran TV. Transition metals in control of gene expression. Science. 1993; 261(5122): 715-25.

246. Matts RL, Schatz JR, Hurst R, Kagen R. Toxic heavy metal ions inhibit reduction of disulfide bonds. J Biol Chem. 1991; 266(19): 12695-702.

247. Boot JH. Effects of SH-blocking compounds on the energy metabolism in isolated rat hepatocytes. Cell Struct Funct. 1995; 20(3): 233-8.

248. Wilson D. Fateful Harvest. New York: Harper Collins; 2001.

249. Crump KS, Kjellstrom T, Shipp AM, Silvers A, Stewart A. Influence of prenatal mercury exposure upon scholastic and psychological test performance: Benchmark analysis of a New Zealand cohort. Risk Analysis. 1998; 18(6): 701-13.

250. Grandjean P, Weihe P, Murata K, Sorensen N, Dahl R, Jorgensen PJ. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997; 19(6): 417-28.

251. Geier M.R., Geier DA. Thimerosal in childhood Vaccines: Neurodevelopmental disorders, and heart disease in the U.S. J of Amer Physicians and Surgeons. 2003; 8(1).

252. Waly M, Olteanu H, Deth R C, et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: A target for neurodevelopmental toxins and thimerosal. Mol Psychiatry. 2004.

253. Weihe P, Debes F, White RF, Sorensen N, Keiding N, Grandjean P. Environmental epidemiology research leads to a decrease of the exposure limit for mercury. Ugeskr Laeger. 2003; 165(2):107-11.

254. Jorgensen PJ, Dahl R, Grandjean P, Wahl P, White RF, Sorensen N. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997; 19(6): 417-428.

255. Masters R, Hone B, and Doshi A. Environmental pollution, neurotoxicity, and criminal violence. In: Rose J, ed. Environmental Toxicology: Current Developments. London: Gordon and Breach; 1998: 13-48.

256. Masters RD, Coplan MJ, Hone B, et al. Brain biochemistry and the violence epidemic: Toward a “win-win” strategy for reducing crime. In: Nagel S, ed. Super-Optimizing Examples Across Public Policy Problems. NOVA Science Publishers; 2003.

257. Masters RD, Coplan M J. Water treatment with silicofluorides and lead toxicity. International Journal of Environmental Studies. 1999; 56: 435-49.

258. Masters RD, Coplan MJ, Hone BT, Dykes JE. Association of silicofluoride treated water with elevated blood lead. Neurotoxicology. 2000; 21: 101-1100.

259. Goodman, Gillman. The Pharmacological Basis of Therapeutics. New York: Mac Millan Publishing Company;1985.

260. DrewA. Poisoning. 5th Ed. Springfield, IL: Charles C. Thomas-Publisher; 1986.

261. Haddad, Shannon, Winchester. Clinical Management of Poisoning. 3rd ed. Philadelphia: W.B. Saunders and Company; 1998: 753.

262. Susser E, et al. Prenatal lead exposure linked to schizophrenia. Environ Health Perspect. 2004.

263. Sood PP, Vijayalakshmi K, Bapu C. Ameliorative capacities of vitamins and monothiols administered alone or in combinations in methylmercury mobilisation in nervous and non-nervous tissues of mice. Cell Mol Biol. 1993; 39(2): 213-9.

264. Torrente M, Colomina MT, Domingo JL. Metal concentrations in hair and cognitive assessment in an adolescent population. Biol Trace Elem Res. 2005; 104(3): 215-21.

265. Arnold LE, Bozzolo H, Hollway J, Williams C, et al. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005; 15(4): 628-36.

266. Yorbik O, Olgun A, Kirmizigul P, Akman S. Plasma zinc and copper levels in boys with oppositional defiant disorder. Turk Psikiyatri Derg. 2004; 15(4): 276-81.

267. Konofal E, Lecendreux M, Arnulf I, Mouren MC. Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2004; 158(12):1113-5.

268. Bilici M, Yildirim F, Aksu H, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28(1):181-90.

269. Stanley PC, Wakwe VC. Toxic trace metals in the mentally ill patients. Niger Postgrad Med J. 2002; 9(4):199-204.

270. Tokdemir M, Polat SA, et al. Blood zinc and copper concentrations in criminal and noncriminal schizophrenic men. Arch Androl. 2003; 49(5): 365-8.

271. Vojnik M, et al. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry. 1985; 20(2):163-71.

272. Braun J, et al. Prenatal exposure to cigarette smoke and neonatal exposure to lead linked to ADHD incidence. Environ Health Perspect. 2006.

273. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem. 2004; 98: 266-75.

274. Shukla PK, Khanna VK, Khan MY, Srimal RC. Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol. 2003; 22: 653-8.

275. Kidd PM. Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev. 2002; 7(6): 472-99.

276. Niederhofer H. Ginkgo biloba treating patients with attention-deficit disorder. Phytother Res. 2009.

277. Laks DR, et al. Mercury has an affinity for pituitary hormones. Med Hyp. 2009.

278. Rhyu IJ, Bytheway JA, Kohler SJ. Effects of aerobic exercise training on cognitive function and cortical vascularity in monkeys. Neuroscience. 2010; 167(4): 1239-48. www.ncbi.nlm.nih.gov/pubmed/20211699

Print Friendly